IL6 and cancer: As inflammation is an important biological process involved in muscle wasting, especially in cancer-associated cachexia, several preclinical studies on rodent cancer models have reported that inhibiting IL-6 and its signaling pathways may have beneficial effect on muscle wasting (Belizário et al., 2016).